Click on image to open expanded view
Item No.
50733-2
You may also like
Product Description
Prestige 4 (Encephalomyelitis / Influenza / Tetanus) Equine Vaccine is indicated for use on healthy horses 6 months of age or older and protects against Equine Encephalomyelitis Viruses (Eastern and Western), Tetanus Toxoid and the influenza (EIV). Available in single dose syringe or 10 ds vial.
*This item can't be shipped to MN.
What is Prestige 4?
For vaccination of healthy horses 6 months of age or older, as an aid in the prevention of disease caused by Eastern and Western encephalomyelitis viruses and tetanus and as an aid in the control of respiratory disease and as an aid in the reduction of virus shedding caused by the influenza (EIV).
Who is Prestige 4 for?
Horses (6 months of age or older)
Why use Prestige 4?
-Protects against costly diseases such as Equine Encephalomyelitis Viruses (Eastern and Western), Tetanus Toxoid and the influenza (EIV)
How does Prestige 4 work?
Killed/modified viruses provide immunity against Encephalomyelitis Viruses (Eastern and Western), Tetanus Toxoid and the influenza (EIV)
Manufacturer:
Merck Animal Health.
How is Prestige 4 sold?
1 dose syringe or 10 dose vial
What are the side effects of Prestige 4?
Local reaction may occur if this product is given subcutaneously. Inject deep into the muscle only. Anaphylactic reactions may occur. If allergic reaction occurs, treat with epinephrine.
What special precautions are there?
Keep away from children and animals. Do not vaccinate within 21 days before slaughter.
What to do if overdose?
Contact your nearest emergency animal hospital. You may also contact Merck Animal Health Pharmacovigilance: Equine Technical Services, 866-349-3497
How can I store Prestige 4?
Store at 2°-7°C (35°-45°F).
Overview
For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 3 - 4 weeks. Annual revaccination is recommended. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported.
Main Ingredients
A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine influenza virus type H3N8 strains (EIV A/Equine 2/ Kentucky/93 American, EIV A/Equine 2/Kentucky/02 American and EIV A/Equine 2/Newmarket/2/93 Eurasian) and tetanus toxoid.